Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya

In today’s Pharmaceutical Executive Daily, the FDA approves an expanded indication for Palynziq in patients aged 12 and older, Sogroya becomes the fi…

8 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Hernexeos
Pharmaceutical Executive Daily: FDA Approves Hernexeos

In today’s Pharmaceutical Executive Daily, the FDA approves Hernexeos under a national priority voucher program, industry leaders explore the expansi…

8 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan
Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan

In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership chan…

8 months, 3 weeks ago

Short Long
View Episode
The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?
The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?

The episode will explore structural implications for supply chains, distribution models, and international strategy, not a political discussion, but …

8 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Braftovi
Pharmaceutical Executive Daily: FDA Approves Braftovi

In today’s Pharmaceutical Executive Daily, the FDA approves Braftovi for mutant metastatic colorectal cancer, Novo Nordisk and GSK announce major dea…

8 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products
Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products

In today’s Pharmaceutical Executive Daily, AbbVie invests $380 million to expand API manufacturing capacity while Bora Pharmaceuticals and GSK enter …

8 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna
Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna

In today’s Pharmaceutical Executive Daily, BioNTech files a patent infringement lawsuit against Moderna, the Supreme Court rules against a large numb…

8 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals
Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals

In today’s Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billi…

8 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine
Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine

In today’s Pharmaceutical Executive Daily, the FDA begins reviewing Moderna’s seasonal flu vaccine under a revised regulatory approach, Eli Lilly sig…

9 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro
Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro

In today’s Pharmaceutical Executive Daily, the FDA approves a monthly dosing schedule for Rybrevant Faspro, HHS Secretary Robert F. Kennedy Jr. revis…

9 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us